Solv Multi-Pass Hemodialysis System In-Center Clinical Study

Part of paid clinical trials in Greenville, South Carolina.

Sponsor
Mozarc Medical US LLC
Study ID
NCT07216885
Status
Recruiting
Apply to this trial

Conditions

  • End Stage Renal Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Solv Multi-Pass Hemodialysis System — DEVICE
    Solv Multi-Pass Hemodialysis System

Study Details

Solv In-Center clinical study is a pre-market, prospective, multicenter, single arm, open-label clinical study. The patient population will include patients with kidney failure or insufficiency requiring hemodialysis and/or ultrafiltration. Eligibility will be open to incident dialysis patients and patients currently receiving HD in an in-center environment. All vascular access types including AV-fistula, AV-graft, and tunneled hemodialysis catheters.

Key Dates

Start date
Jan 13, 2026
Status verified
Mar 2026
Primary completion
Jul 31, 2026
Completion
Jul 31, 2026

Study Design

Enrollment
46 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Solv Multi-Pass Hemodialysis System In-Center Subjects
    All subjects enrolled in the study and treated with the Solv Multi-Pass Hemodialysis System

Primary Outcome Measure

Primary Safety Endpoint [ Time Frame: through study completion, an average of 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Carolina NephrologyGreenvilleSouth Carolina29605
Barry Gorlitsky
862-271-1844
Barry Gorlitsky (PRINCIPAL_INVESTIGATOR)

Find similar trials in Greenville, SC

By research site
Carolina Nephrology· Greenville, SC

Related Studies